Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (81-90 of 331) with videos related to

Pageof 34
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1996
Retinoid differentiation therapy in promyelocytic leukemiaC Chomienne, P Fenaux, L Degos
Best Practice & Research. Clinical Haematology|May 18, 2001
Treatment of acute promyelocytic leukaemiaP Fenaux, C Chomienne, L Degos
Tissue Antigens|June 1, 1975
Descriptive serological analysisV Lepage, L Degos, J Dausset
The New England Journal of Medicine|September 6, 1979
Therapeutic complications in acute myelogenous leukemiaD J Charron, T Schmitt, L Degos
Journal of Immunological Methods|June 24, 1986
Human T lymphocyte clones with killer or natural killer activityJ F Bourge, L Degos, A Bensussan
Nouvelle Revue Francaise D'Hematologie|November 1, 1971
[The preleukemic thrombopenias. (Apropos of 3 cases)]L Degos, G el-Yafi, J Bernard
Current Topics in Microbiology and Immunology|January 16, 2007
Treatment of acute promyelocytic leukemia by retinoidsP Fenaux, Z Z Wang, L Degos
Blood|June 1, 1989
TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cellsA Bensussan, J F Lagabrielle, L Degos
Advances in Experimental Medicine and Biology|January 1, 1980
Clinical investigation of lithium therapy in acute leukemiaD J Charron, T Schmitt, L Degos
British Journal of Haematology|May 1, 1982
Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?M Housset, M T Daniel, L Degos
Pageof 34

Showing results (81-90 of 331) with videos related to

Sort By:
Pageof 34
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1996
Retinoid differentiation therapy in promyelocytic leukemiaC Chomienne, P Fenaux, L Degos
Best Practice & Research. Clinical Haematology|May 18, 2001
Treatment of acute promyelocytic leukaemiaP Fenaux, C Chomienne, L Degos
Tissue Antigens|June 1, 1975
Descriptive serological analysisV Lepage, L Degos, J Dausset
The New England Journal of Medicine|September 6, 1979
Therapeutic complications in acute myelogenous leukemiaD J Charron, T Schmitt, L Degos
Journal of Immunological Methods|June 24, 1986
Human T lymphocyte clones with killer or natural killer activityJ F Bourge, L Degos, A Bensussan
Nouvelle Revue Francaise D'Hematologie|November 1, 1971
[The preleukemic thrombopenias. (Apropos of 3 cases)]L Degos, G el-Yafi, J Bernard
Current Topics in Microbiology and Immunology|January 16, 2007
Treatment of acute promyelocytic leukemia by retinoidsP Fenaux, Z Z Wang, L Degos
Blood|June 1, 1989
TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cellsA Bensussan, J F Lagabrielle, L Degos
Advances in Experimental Medicine and Biology|January 1, 1980
Clinical investigation of lithium therapy in acute leukemiaD J Charron, T Schmitt, L Degos
British Journal of Haematology|May 1, 1982
Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?M Housset, M T Daniel, L Degos
Pageof 34